
### [NCIT:C7478](http://purl.obolibrary.org/obo/NCIT_C7478)
**Label:** Malignant Esophageal Neoplasm

**Subclasses:** [NCIT:C5687](http://purl.obolibrary.org/obo/NCIT_C5687) (Esophageal Lymphoma), [NCIT:C5688](http://purl.obolibrary.org/obo/NCIT_C5688) (Esophageal Non-Hodgkin Lymphoma), [NCIT:C5689](http://purl.obolibrary.org/obo/NCIT_C5689) (Esophageal Hodgkin Lymphoma), [NCIT:C8632](http://purl.obolibrary.org/obo/NCIT_C8632) (Stage IV Esophageal Adenocarcinoma AJCC v7), [NCIT:C95620](http://purl.obolibrary.org/obo/NCIT_C95620) (Esophageal Large Cell Neuroendocrine Carcinoma), [NCIT:C8633](http://purl.obolibrary.org/obo/NCIT_C8633) (Recurrent Esophageal Squamous Cell Carcinoma), [NCIT:C7027](http://purl.obolibrary.org/obo/NCIT_C7027) (Barrett Adenocarcinoma), [NCIT:C8630](http://purl.obolibrary.org/obo/NCIT_C8630) (Stage I Esophageal Adenocarcinoma AJCC v7), [NCIT:C8631](http://purl.obolibrary.org/obo/NCIT_C8631) (Stage III Esophageal Adenocarcinoma AJCC v7), [NCIT:C95626](http://purl.obolibrary.org/obo/NCIT_C95626) (Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C95625](http://purl.obolibrary.org/obo/NCIT_C95625) (Esophageal Diffuse Large B-Cell Lymphoma), [NCIT:C95623](http://purl.obolibrary.org/obo/NCIT_C95623) (Esophageal Rhabdomyosarcoma), [NCIT:C91221](http://purl.obolibrary.org/obo/NCIT_C91221) (Esophageal Cancer by AJCC v7 Stage), [NCIT:C95621](http://purl.obolibrary.org/obo/NCIT_C95621) (Esophageal Mixed Adenoneuroendocrine Carcinoma), [NCIT:C89771](http://purl.obolibrary.org/obo/NCIT_C89771) (Stage 0 Esophageal Cancer AJCC v7), [NCIT:C5019](http://purl.obolibrary.org/obo/NCIT_C5019) (Stage IV Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C3999](http://purl.obolibrary.org/obo/NCIT_C3999) (Recurrent Esophageal Carcinoma), [NCIT:C5334](http://purl.obolibrary.org/obo/NCIT_C5334) (Esophageal Leiomyosarcoma), [NCIT:C7479](http://purl.obolibrary.org/obo/NCIT_C7479) (Metastatic Malignant Neoplasm in the Esophagus), [NCIT:C133411](http://purl.obolibrary.org/obo/NCIT_C133411) (Esophageal Adenocarcinoma by AJCC v7 Stage), [NCIT:C3513](http://purl.obolibrary.org/obo/NCIT_C3513) (Esophageal Carcinoma), [NCIT:C89804](http://purl.obolibrary.org/obo/NCIT_C89804) (Stage IV Esophageal Cancer AJCC v7), [NCIT:C9213](http://purl.obolibrary.org/obo/NCIT_C9213) (Stage IV Esophageal Cancer AJCC v6), [NCIT:C9211](http://purl.obolibrary.org/obo/NCIT_C9211) (Stage II Esophageal Cancer AJCC v6), [NCIT:C9212](http://purl.obolibrary.org/obo/NCIT_C9212) (Stage III Esophageal Cancer AJCC v6), [NCIT:C9210](http://purl.obolibrary.org/obo/NCIT_C9210) (Stage I Esophageal Cancer AJCC v6), [NCIT:C90500](http://purl.obolibrary.org/obo/NCIT_C90500) (Esophageal Cancer by AJCC v6 Stage), [NCIT:C27928](http://purl.obolibrary.org/obo/NCIT_C27928) (Alcohol-Related Esophageal Squamous Cell Carcinoma), [NCIT:C3637](http://purl.obolibrary.org/obo/NCIT_C3637) (Stage 0 Esophageal Cancer AJCC v6), [NCIT:C133442](http://purl.obolibrary.org/obo/NCIT_C133442) (Esophageal Squamous Cell Carcinoma by AJCC v7 Stage), [NCIT:C133443](http://purl.obolibrary.org/obo/NCIT_C133443) (Esophageal Squamous Cell Carcinoma by AJCC v8 Stage), [NCIT:C133400](http://purl.obolibrary.org/obo/NCIT_C133400) (Esophageal Adenocarcinoma by AJCC v8 Stage), [NCIT:C5341](http://purl.obolibrary.org/obo/NCIT_C5341) (Esophageal Sarcoma), [NCIT:C5022](http://purl.obolibrary.org/obo/NCIT_C5022) (Stage I Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C5023](http://purl.obolibrary.org/obo/NCIT_C5023) (Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C5342](http://purl.obolibrary.org/obo/NCIT_C5342) (Esophageal Adenoid Cystic Carcinoma), [NCIT:C5343](http://purl.obolibrary.org/obo/NCIT_C5343) (Esophageal Mucoepidermoid Carcinoma), [NCIT:C5020](http://purl.obolibrary.org/obo/NCIT_C5020) (Stage III Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C5021](http://purl.obolibrary.org/obo/NCIT_C5021) (Stage II Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C89795](http://purl.obolibrary.org/obo/NCIT_C89795) (Stage III Esophageal Cancer AJCC v7), [NCIT:C89794](http://purl.obolibrary.org/obo/NCIT_C89794) (Stage II Esophageal Cancer AJCC v7), [NCIT:C5705](http://purl.obolibrary.org/obo/NCIT_C5705) (Esophageal Liposarcoma), [NCIT:C89793](http://purl.obolibrary.org/obo/NCIT_C89793) (Stage I Esophageal Cancer AJCC v7), [NCIT:C5706](http://purl.obolibrary.org/obo/NCIT_C5706) (Esophageal Kaposi Sarcoma), [NCIT:C95608](http://purl.obolibrary.org/obo/NCIT_C95608) (Esophageal Spindle Cell Carcinoma), [NCIT:C5707](http://purl.obolibrary.org/obo/NCIT_C5707) (Esophageal Melanoma), [NCIT:C8629](http://purl.obolibrary.org/obo/NCIT_C8629) (Stage 0 Esophageal Adenocarcinoma AJCC v7), [NCIT:C27421](http://purl.obolibrary.org/obo/NCIT_C27421) (Esophageal Adenosquamous Carcinoma), [NCIT:C133399](http://purl.obolibrary.org/obo/NCIT_C133399) (Esophageal Cancer by AJCC v8 Stage), [NCIT:C8627](http://purl.obolibrary.org/obo/NCIT_C8627) (Recurrent Esophageal Adenocarcinoma), [NCIT:C27422](http://purl.obolibrary.org/obo/NCIT_C27422) (Esophageal Undifferentiated Carcinoma), [NCIT:C8628](http://purl.obolibrary.org/obo/NCIT_C8628) (Stage II Esophageal Adenocarcinoma AJCC v7), [NCIT:C4025](http://purl.obolibrary.org/obo/NCIT_C4025) (Esophageal Adenocarcinoma), [NCIT:C92185](http://purl.obolibrary.org/obo/NCIT_C92185) (Malignant Esophageal Peripheral Nerve Sheath Tumor), [NCIT:C4024](http://purl.obolibrary.org/obo/NCIT_C4024) (Esophageal Squamous Cell Carcinoma), [NCIT:C6762](http://purl.obolibrary.org/obo/NCIT_C6762) (Esophageal Small Cell Neuroendocrine Carcinoma), [NCIT:C95612](http://purl.obolibrary.org/obo/NCIT_C95612) (Esophageal Poorly Differentiated Squamous Cell Carcinoma), [NCIT:C95611](http://purl.obolibrary.org/obo/NCIT_C95611) (Esophageal Moderately Differentiated Squamous Cell Carcinoma), [NCIT:C95610](http://purl.obolibrary.org/obo/NCIT_C95610) (Esophageal Well Differentiated Squamous Cell Carcinoma), [NCIT:C118812](http://purl.obolibrary.org/obo/NCIT_C118812) (Childhood Esophageal Carcinoma), [NCIT:C95619](http://purl.obolibrary.org/obo/NCIT_C95619) (Esophageal Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36122](http://purl.obolibrary.org/obo/NCIT_C36122) (Benign Cellular Infiltrate) 75.00%
- Thing 51.13%
- [NCIT:C42077](http://purl.obolibrary.org/obo/NCIT_C42077) (Cellular Infiltrate) 36.79%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 28.24%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 27.58%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 27.48%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 27.48%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 27.37%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 26.79%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 26.52%
- CP:0000037 0.00%
- CP:0000035 0.00%
- CP:0000028 0.00%
- CP:0000027 0.00%
- CP:0000000 0.00%


